Phase II study on the addition of ASA404 (vadimezan; 5,6- dimethylxanthenone-4-acetic acid) to docetaxel in CRMPC

R. Pili; M.A. Rosenthal; P.N. Mainwaring; Guy Van Hazel; S. Srinivas; R. Dreicer; S. Goel; J. Leach; S. Wong; P. Clingan

doi:10.1158/1078-0432.CCR-09-3026

Phase II study on the addition of ASA404 (vadimezan; 5,6- dimethylxanthenone-4-acetic acid) to docetaxel in CRMPC

R. Pili, M.A. Rosenthal, P.N. Mainwaring, Guy Van Hazel, S. Srinivas, R. Dreicer, S. Goel, J. Leach, S. Wong, P. Clingan

Research output: Contribution to journal › Article › peer-review

52 Citations (Scopus)

Original language	English
Pages (from-to)	2906-2914
Journal	Clinical Cancer Research
Volume	16
Issue number	10
DOIs	https://doi.org/10.1158/1078-0432.CCR-09-3026
Publication status	Published - 2010

Access to Document

10.1158/1078-0432.CCR-09-3026

Cite this

@article{6f45a3d6996241dfa83078e72fdcaa38,

title = "Phase II study on the addition of ASA404 (vadimezan; 5,6- dimethylxanthenone-4-acetic acid) to docetaxel in CRMPC",

author = "R. Pili and M.A. Rosenthal and P.N. Mainwaring and {Van Hazel}, Guy and S. Srinivas and R. Dreicer and S. Goel and J. Leach and S. Wong and P. Clingan",

year = "2010",

doi = "10.1158/1078-0432.CCR-09-3026",

language = "English",

volume = "16",

pages = "2906--2914",

journal = "Clinical Cancer Reserach",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "10",

}

TY - JOUR

T1 - Phase II study on the addition of ASA404 (vadimezan; 5,6- dimethylxanthenone-4-acetic acid) to docetaxel in CRMPC

AU - Pili, R.

AU - Rosenthal, M.A.

AU - Mainwaring, P.N.

AU - Van Hazel, Guy

AU - Srinivas, S.

AU - Dreicer, R.

AU - Goel, S.

AU - Leach, J.

AU - Wong, S.

AU - Clingan, P.

PY - 2010

Y1 - 2010

U2 - 10.1158/1078-0432.CCR-09-3026

DO - 10.1158/1078-0432.CCR-09-3026

M3 - Article

C2 - 20460477

VL - 16

SP - 2906

EP - 2914

JO - Clinical Cancer Reserach

JF - Clinical Cancer Reserach

SN - 1078-0432

IS - 10

ER -